Clinical Trial Update: A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1） [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CM512 in chronic rhinosinusitis with nasal polyps (NEZHA-1). The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• CM512

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Chronic Rhinosinusitis With Nasal Polyposis | Phase 2 | Status: NOT_YET_RECRUITING